Cargando…
Relaxin in fibrotic ligament diseases: Its regulatory role and mechanism
Fibrotic ligament diseases (FLDs) are diseases caused by the pathological accumulation of periarticular fibrotic tissue, leading to functional disability around joint and poor life quality. Relaxin (RLX) has been reported to be involved in the development of fibrotic lung and liver diseases. Previou...
Autores principales: | Yuan, Shuai, Guo, Dong, Liang, Xinzhi, Zhang, Luhui, Zhang, Qun, Xie, Denghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134402/ https://www.ncbi.nlm.nih.gov/pubmed/37123405 http://dx.doi.org/10.3389/fcell.2023.1131481 |
Ejemplares similares
-
Aberrant regulation of autophagy disturbs fibrotic liver regeneration after partial hepatectomy
por: Lian, Yuan-E., et al.
Publicado: (2022) -
New insights into fibrotic signaling in renal cell carcinoma
por: Chen, Jiao-Yi, et al.
Publicado: (2023) -
The Pro-fibrotic Response of Mesenchymal Leader Cells to Lens Wounding Involves Hyaluronic Acid, Its Receptor RHAMM, and Vimentin
por: Menko, A. Sue, et al.
Publicado: (2022) -
Autophagy, Pyroptosis, and Ferroptosis: New Regulatory Mechanisms for Atherosclerosis
por: Lin, Lin, et al.
Publicado: (2022) -
The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders
por: Di Gregorio, Jacopo, et al.
Publicado: (2020)